Literature DB >> 29155234

Survivin and autoimmunity; the ins and outs.

Hamidreza Ebrahimiyan1, Saeed Aslani2, Nima Rezaei3, Ahmadreza Jamshidi2, Mahdi Mahmoudi4.   

Abstract

Autoimmunity is a status that immune mechanisms react against self-structure. The immune mechanisms, including cellular and molecular elements have been developed to immune body against foreign invades. Multiple factors such as genetic and epigenetic background, hormonal status, microbiome, and other factors can cause launching the autoreactive responses, in which the immune tolerance breaks and immune mechanisms are against self-antigens. Apoptosis is one of the important mechanisms in maintaining the tolerance and eliminating the autoreactive lymphocyte clones. Due to survivin roles in apoptosis and proliferation, numerous researches have been paying attention to survivin expression and function in autoreactive lymphocytes and tissue cells, playing important roles in the pathogenesis of autoimmune diseases. New line of evidence has been supporting the role of survivin dysfunction or aberrant expression in deriving autoreactive lymphocytes or some important immune tissues, which may underpin the autoimmune conditions such as Lichen planus (LP), Rheumatoid arthritis (RA), Systemic lupus erythematosus (SLE), Myasthenia gravis (MG), Multiple sclerosis (MS), Systemic sclerosis (SSc), Psoriasis, and Inflammatory bowel disease (IBD). Hence, the purpose of the current paper was to review the survivin role in the etiology and pathogenesis of abovementioned autoimmune diseases.
Copyright © 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autoimmune diseases; Survivin

Mesh:

Substances:

Year:  2017        PMID: 29155234     DOI: 10.1016/j.imlet.2017.11.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

Review 1.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

2.  The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model.

Authors:  Xiangyang Zhang; Michael Ciesielski; Robert A Fenstermaker; Henry J Kaminski; Linda L Kusner
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

3.  Appendectomy and rheumatoid arthritis: A longitudinal follow-up study using a national sample cohort.

Authors:  Hyo Geun Choi; Dong Jun Oh; Miyoung Kim; Sunmi Kim; Chanyang Min; Il Gyu Kong
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

4.  Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients.

Authors:  Dariush Rahban; Forogh Mohammadi; Mehdi Alidadi; Taha Ghantabpour; Pedram Abbasi Ghasem Kheyli; Majid Ahmadi
Journal:  BMC Immunol       Date:  2019-08-22       Impact factor: 3.615

Review 5.  Environmental Influencers, MicroRNA, and Multiple Sclerosis.

Authors:  Eiman Ma Mohammed
Journal:  J Cent Nerv Syst Dis       Date:  2020-01-20

6.  Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis.

Authors:  Marianna Miliaraki; Panagiotis Briassoulis; Stavroula Ilia; Aikaterini Polonifi; Marina Mantzourani; Efrossini Briassouli; Konstantinos Vardas; Serafim Nanas; Aikaterini Pistiki; Maria Theodorakopoulou; Theonymfi Tavladaki; Anna Maria Spanaki; Eumorfia Kondili; Helen Dimitriou; Sotirios Tsiodras; Dimitrios Georgopoulos; Apostolos Armaganidis; George Daikos; George Briassoulis
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.

Authors:  Joanna Lipinska; Marcin Kaszkowiak; Beata Malachowska; Joanna Swidrowska-Jaros; Elzbieta Smolewska
Journal:  Arthritis Res Ther       Date:  2021-01-26       Impact factor: 5.156

8.  Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs.

Authors:  Wei Guo; Xingyuan Ma; Yunhui Fu; Chang Liu; Qiuli Liu; Fabiao Hu; Hui Miao; Tong Zhang; Yuping Liu; Myong Hun Han; Fang You; Yi Yang; Wenyun Zheng
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

9.  A novel strategy to promote liver regeneration: utilization of secretome obtained from survivin-overexpressing adipose-derived stem cells.

Authors:  Cho-Hee Kim; Ok-Hee Kim; Jung Hyun Park; Say-June Kim
Journal:  Ann Surg Treat Res       Date:  2021-12-01       Impact factor: 1.859

10.  Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer.

Authors:  Xiaoxi Zhu; Renyu Zhou; Yuanzhi Lu; Ying Zhang; Qiang Chen; Yin Li
Journal:  Front Oncol       Date:  2021-11-03       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.